 John Rinn
Concepts (582)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 64 | 2024 | 171 | 17.060 |
Why?
| | RNA, Untranslated | 27 | 2021 | 124 | 5.980 |
Why?
| | Gene Expression Regulation | 49 | 2024 | 2590 | 4.420 |
Why?
| | Chromatin | 26 | 2023 | 515 | 3.780 |
Why?
| | RNA | 17 | 2024 | 925 | 2.730 |
Why?
| | Cell Nucleus | 14 | 2025 | 607 | 2.530 |
Why?
| | Transcription, Genetic | 29 | 2024 | 1470 | 2.340 |
Why?
| | Genome | 12 | 2022 | 299 | 2.230 |
Why?
| | Epigenesis, Genetic | 18 | 2024 | 639 | 2.160 |
Why?
| | Genome, Human | 18 | 2021 | 416 | 2.140 |
Why?
| | RNA, Messenger | 25 | 2021 | 2815 | 1.910 |
Why?
| | Enhancer Elements, Genetic | 10 | 2020 | 189 | 1.900 |
Why?
| | Promoter Regions, Genetic | 16 | 2021 | 1233 | 1.900 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2017 | 525 | 1.810 |
Why?
| | RNA-Binding Proteins | 15 | 2024 | 431 | 1.790 |
Why?
| | Repetitive Sequences, Nucleic Acid | 3 | 2021 | 114 | 1.630 |
Why?
| | Models, Genetic | 8 | 2018 | 590 | 1.590 |
Why?
| | Sequence Analysis, RNA | 14 | 2019 | 448 | 1.370 |
Why?
| | Transcriptome | 12 | 2025 | 967 | 1.360 |
Why?
| | Cell Differentiation | 25 | 2023 | 1992 | 1.340 |
Why?
| | Ribonucleoproteins | 4 | 2025 | 104 | 1.340 |
Why?
| | Telomerase | 4 | 2024 | 246 | 1.320 |
Why?
| | X Chromosome Inactivation | 6 | 2024 | 24 | 1.300 |
Why?
| | Gene Deletion | 6 | 2021 | 388 | 1.300 |
Why?
| | Animals | 92 | 2025 | 37217 | 1.260 |
Why?
| | Introns | 6 | 2025 | 254 | 1.220 |
Why?
| | CCCTC-Binding Factor | 3 | 2024 | 12 | 1.210 |
Why?
| | Fibroblasts | 10 | 2018 | 1003 | 1.160 |
Why?
| | Mice | 60 | 2025 | 17814 | 1.130 |
Why?
| | Base Sequence | 18 | 2020 | 2174 | 1.120 |
Why?
| | Genomics | 13 | 2022 | 796 | 1.080 |
Why?
| | Open Reading Frames | 8 | 2024 | 132 | 1.080 |
Why?
| | Chromosomes | 3 | 2018 | 105 | 1.050 |
Why?
| | DNA, Complementary | 8 | 2020 | 274 | 1.050 |
Why?
| | Genetic Loci | 7 | 2020 | 273 | 1.020 |
Why?
| | Embryonic Stem Cells | 10 | 2015 | 129 | 1.010 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 32 | 1.010 |
Why?
| | RNA Splicing | 7 | 2025 | 270 | 0.970 |
Why?
| | RNA, Nuclear | 1 | 2025 | 5 | 0.960 |
Why?
| | Gene Expression Regulation, Developmental | 16 | 2023 | 873 | 0.940 |
Why?
| | Transcription Factors | 17 | 2020 | 1697 | 0.890 |
Why?
| | Molecular Sequence Annotation | 7 | 2020 | 95 | 0.890 |
Why?
| | Gene Expression Profiling | 29 | 2020 | 1746 | 0.860 |
Why?
| | Hematopoiesis | 3 | 2021 | 193 | 0.850 |
Why?
| | Humans | 121 | 2025 | 138651 | 0.840 |
Why?
| | DNA Damage | 2 | 2017 | 422 | 0.820 |
Why?
| | Cell Line | 17 | 2024 | 2876 | 0.810 |
Why?
| | Mice, Knockout | 14 | 2024 | 3028 | 0.810 |
Why?
| | Induced Pluripotent Stem Cells | 7 | 2021 | 248 | 0.800 |
Why?
| | Fertility | 2 | 2020 | 163 | 0.750 |
Why?
| | Microscopy, Confocal | 3 | 2018 | 324 | 0.750 |
Why?
| | Pluripotent Stem Cells | 6 | 2022 | 80 | 0.730 |
Why?
| | Regulatory Elements, Transcriptional | 4 | 2020 | 18 | 0.730 |
Why?
| | Binding Sites | 13 | 2024 | 1313 | 0.730 |
Why?
| | Polycomb Repressive Complex 2 | 5 | 2020 | 66 | 0.700 |
Why?
| | Computational Biology | 7 | 2021 | 649 | 0.700 |
Why?
| | Cellular Reprogramming | 4 | 2018 | 98 | 0.680 |
Why?
| | Cytoplasm | 3 | 2022 | 270 | 0.670 |
Why?
| | Hemorrhagic Fever, Ebola | 4 | 2023 | 78 | 0.670 |
Why?
| | Ebolavirus | 4 | 2023 | 87 | 0.660 |
Why?
| | Evolution, Molecular | 4 | 2020 | 506 | 0.660 |
Why?
| | Sequence Deletion | 3 | 2020 | 183 | 0.660 |
Why?
| | DNA | 7 | 2022 | 1438 | 0.650 |
Why?
| | Body Patterning | 4 | 2008 | 135 | 0.650 |
Why?
| | Nucleic Acid Conformation | 7 | 2024 | 722 | 0.640 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2020 | 2113 | 0.620 |
Why?
| | K562 Cells | 5 | 2021 | 91 | 0.620 |
Why?
| | Embryonic Development | 6 | 2019 | 117 | 0.610 |
Why?
| | Repressor Proteins | 7 | 2018 | 420 | 0.610 |
Why?
| | Oligonucleotide Array Sequence Analysis | 17 | 2016 | 761 | 0.600 |
Why?
| | DNA-Binding Proteins | 7 | 2021 | 1471 | 0.600 |
Why?
| | Alleles | 6 | 2024 | 887 | 0.600 |
Why?
| | In Situ Hybridization, Fluorescence | 7 | 2021 | 310 | 0.590 |
Why?
| | Organ Specificity | 6 | 2019 | 310 | 0.580 |
Why?
| | Molecular Sequence Data | 10 | 2015 | 2923 | 0.560 |
Why?
| | Time-Lapse Imaging | 1 | 2018 | 21 | 0.560 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 819 | 0.560 |
Why?
| | Chromosomes, Human | 1 | 2018 | 44 | 0.560 |
Why?
| | Chromosomes, Human, X | 1 | 2018 | 75 | 0.550 |
Why?
| | Endogenous Retroviruses | 2 | 2022 | 38 | 0.550 |
Why?
| | Chromosome Aberrations | 1 | 2018 | 159 | 0.550 |
Why?
| | DNA Methylation | 8 | 2022 | 629 | 0.540 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 434 | 0.540 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2019 | 1388 | 0.510 |
Why?
| | Phenotype | 8 | 2024 | 3139 | 0.490 |
Why?
| | Genomic Imprinting | 3 | 2024 | 26 | 0.490 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 122 | 0.480 |
Why?
| | High-Throughput Nucleotide Sequencing | 6 | 2018 | 540 | 0.480 |
Why?
| | DNA, Satellite | 1 | 2015 | 18 | 0.480 |
Why?
| | Gene Regulatory Networks | 7 | 2018 | 309 | 0.480 |
Why?
| | Homeodomain Proteins | 6 | 2013 | 509 | 0.480 |
Why?
| | DNA, Intergenic | 4 | 2011 | 29 | 0.470 |
Why?
| | Plasmodium falciparum | 2 | 2015 | 30 | 0.470 |
Why?
| | Genes, Homeobox | 5 | 2013 | 51 | 0.460 |
Why?
| | Centromere | 1 | 2015 | 59 | 0.460 |
Why?
| | Neoplasms | 5 | 2019 | 2681 | 0.460 |
Why?
| | DNA Transposable Elements | 1 | 2014 | 118 | 0.420 |
Why?
| | Nuclear Proteins | 3 | 2016 | 706 | 0.420 |
Why?
| | Protein Binding | 12 | 2024 | 2225 | 0.410 |
Why?
| | X Chromosome | 3 | 2024 | 54 | 0.410 |
Why?
| | Myoblasts | 3 | 2022 | 81 | 0.410 |
Why?
| | HeLa Cells | 8 | 2021 | 637 | 0.400 |
Why?
| | Systems Biology | 3 | 2011 | 70 | 0.400 |
Why?
| | Proteins | 7 | 2024 | 1006 | 0.400 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 150 | 0.400 |
Why?
| | RNA Interference | 7 | 2021 | 468 | 0.390 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2014 | 147 | 0.390 |
Why?
| | Adipogenesis | 1 | 2013 | 57 | 0.380 |
Why?
| | Retroelements | 1 | 2012 | 48 | 0.380 |
Why?
| | HEK293 Cells | 7 | 2021 | 728 | 0.380 |
Why?
| | Homeostasis | 4 | 2021 | 614 | 0.380 |
Why?
| | Cells, Cultured | 16 | 2021 | 4181 | 0.380 |
Why?
| | Skin | 2 | 2008 | 754 | 0.380 |
Why?
| | Brain | 2 | 2015 | 2792 | 0.380 |
Why?
| | Epidermis | 2 | 2012 | 157 | 0.350 |
Why?
| | RNA Stability | 5 | 2021 | 112 | 0.350 |
Why?
| | Human Embryonic Stem Cells | 2 | 2021 | 25 | 0.350 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 2023 | 92 | 0.340 |
Why?
| | Conserved Sequence | 6 | 2020 | 238 | 0.330 |
Why?
| | Histones | 11 | 2021 | 632 | 0.330 |
Why?
| | Down-Regulation | 3 | 2016 | 635 | 0.330 |
Why?
| | Mouse Embryonic Stem Cells | 3 | 2020 | 30 | 0.320 |
Why?
| | Muscle Development | 3 | 2022 | 114 | 0.320 |
Why?
| | Chromosomes, Human, Pair 22 | 4 | 2004 | 45 | 0.310 |
Why?
| | Telomere | 2 | 2019 | 273 | 0.310 |
Why?
| | Gene Library | 4 | 2018 | 118 | 0.310 |
Why?
| | Single-Cell Analysis | 5 | 2020 | 321 | 0.310 |
Why?
| | Sex Characteristics | 2 | 2005 | 770 | 0.310 |
Why?
| | Gene Editing | 2 | 2021 | 84 | 0.300 |
Why?
| | MicroRNAs | 8 | 2021 | 675 | 0.300 |
Why?
| | CRISPR-Cas Systems | 3 | 2021 | 134 | 0.300 |
Why?
| | Mammals | 5 | 2021 | 286 | 0.300 |
Why?
| | Nucleotide Motifs | 3 | 2017 | 36 | 0.290 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2152 | 0.280 |
Why?
| | Immunity, Innate | 3 | 2019 | 824 | 0.280 |
Why?
| | Cell Lineage | 5 | 2021 | 350 | 0.270 |
Why?
| | Lymphopoiesis | 2 | 2021 | 26 | 0.270 |
Why?
| | Chromatin Assembly and Disassembly | 5 | 2017 | 101 | 0.270 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 30 | 0.270 |
Why?
| | Wnt Proteins | 1 | 2008 | 135 | 0.260 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 3 | 2022 | 15 | 0.250 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 777 | 0.250 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3307 | 0.250 |
Why?
| | HCT116 Cells | 3 | 2021 | 80 | 0.240 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 322 | 0.230 |
Why?
| | Exons | 4 | 2016 | 353 | 0.230 |
Why?
| | Databases, Genetic | 4 | 2020 | 241 | 0.230 |
Why?
| | Genes, X-Linked | 1 | 2024 | 20 | 0.230 |
Why?
| | Myosin Heavy Chains | 2 | 2021 | 177 | 0.220 |
Why?
| | Male | 21 | 2024 | 68260 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 1 | 2008 | 620 | 0.220 |
Why?
| | Motor Neurons | 3 | 2015 | 229 | 0.220 |
Why?
| | Genitalia | 1 | 2004 | 33 | 0.220 |
Why?
| | Signal Transduction | 11 | 2021 | 5086 | 0.210 |
Why?
| | Gene Knockdown Techniques | 4 | 2013 | 329 | 0.210 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2023 | 16 | 0.210 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2019 | 801 | 0.210 |
Why?
| | Alternative Splicing | 2 | 2018 | 227 | 0.200 |
Why?
| | Cluster Analysis | 5 | 2015 | 517 | 0.200 |
Why?
| | Databases, Nucleic Acid | 2 | 2021 | 38 | 0.190 |
Why?
| | Female | 23 | 2024 | 73763 | 0.190 |
Why?
| | Zebrafish | 4 | 2013 | 496 | 0.190 |
Why?
| | Plasmids | 1 | 2023 | 358 | 0.190 |
Why?
| | NF-kappa B | 4 | 2020 | 678 | 0.190 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 176 | 0.190 |
Why?
| | Mitosis | 2 | 2021 | 192 | 0.190 |
Why?
| | Ribonucleases | 2 | 2019 | 48 | 0.180 |
Why?
| | RNA Transport | 3 | 2016 | 23 | 0.180 |
Why?
| | Gene Targeting | 1 | 2021 | 83 | 0.180 |
Why?
| | Genetic Techniques | 2 | 2013 | 67 | 0.180 |
Why?
| | Mice, Inbred Strains | 2 | 2019 | 411 | 0.180 |
Why?
| | Cell Compartmentation | 1 | 2021 | 53 | 0.180 |
Why?
| | Ectoderm | 1 | 2021 | 53 | 0.180 |
Why?
| | Genetic Association Studies | 3 | 2014 | 370 | 0.170 |
Why?
| | Research Report | 1 | 2021 | 86 | 0.170 |
Why?
| | Stem Cells | 3 | 2022 | 599 | 0.170 |
Why?
| | Cardiac Myosins | 1 | 2021 | 31 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 984 | 0.170 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2022 | 216 | 0.170 |
Why?
| | Ikaros Transcription Factor | 1 | 2021 | 24 | 0.170 |
Why?
| | Receptor, Insulin | 1 | 2021 | 100 | 0.170 |
Why?
| | Epigenomics | 2 | 2011 | 113 | 0.170 |
Why?
| | Lipopolysaccharides | 3 | 2019 | 888 | 0.160 |
Why?
| | Spermatogenesis | 1 | 2020 | 69 | 0.160 |
Why?
| | Polycomb-Group Proteins | 3 | 2010 | 28 | 0.160 |
Why?
| | Placenta | 3 | 2021 | 753 | 0.160 |
Why?
| | Telomere Homeostasis | 1 | 2020 | 33 | 0.160 |
Why?
| | Eukaryotic Cells | 1 | 2020 | 40 | 0.160 |
Why?
| | Congresses as Topic | 1 | 2021 | 227 | 0.160 |
Why?
| | Protein Domains | 2 | 2020 | 288 | 0.160 |
Why?
| | RNA Precursors | 1 | 2021 | 155 | 0.160 |
Why?
| | Species Specificity | 1 | 2021 | 581 | 0.160 |
Why?
| | Preimplantation Diagnosis | 1 | 2019 | 5 | 0.160 |
Why?
| | Genome-Wide Association Study | 4 | 2020 | 1374 | 0.160 |
Why?
| | Dactinomycin | 1 | 2019 | 30 | 0.160 |
Why?
| | Immunoprecipitation | 2 | 2024 | 154 | 0.160 |
Why?
| | Embryo Implantation | 1 | 2019 | 30 | 0.160 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 62 | 0.160 |
Why?
| | RNA Processing, Post-Transcriptional | 3 | 2018 | 91 | 0.160 |
Why?
| | Drug Tolerance | 1 | 2019 | 105 | 0.150 |
Why?
| | Mice, Inbred C57BL | 10 | 2024 | 5798 | 0.150 |
Why?
| | Organelles | 2 | 2017 | 57 | 0.150 |
Why?
| | Fertilization in Vitro | 1 | 2019 | 84 | 0.150 |
Why?
| | Structure-Activity Relationship | 1 | 2020 | 575 | 0.150 |
Why?
| | Apoptosis | 4 | 2018 | 2546 | 0.150 |
Why?
| | RNA, Fungal | 2 | 2010 | 73 | 0.150 |
Why?
| | Pattern Recognition, Automated | 1 | 2019 | 74 | 0.150 |
Why?
| | Protein Conformation | 2 | 2021 | 936 | 0.150 |
Why?
| | Time Factors | 4 | 2024 | 6851 | 0.150 |
Why?
| | Transgenes | 3 | 2020 | 185 | 0.150 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 3392 | 0.150 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2018 | 20 | 0.140 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2018 | 28 | 0.140 |
Why?
| | Mutation | 6 | 2024 | 3987 | 0.140 |
Why?
| | Binding, Competitive | 2 | 2020 | 196 | 0.140 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2018 | 55 | 0.140 |
Why?
| | Cell Proliferation | 7 | 2020 | 2480 | 0.140 |
Why?
| | HMGA2 Protein | 1 | 2018 | 8 | 0.140 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 274 | 0.140 |
Why?
| | Molecular Imaging | 1 | 2018 | 55 | 0.140 |
Why?
| | Adipocytes | 1 | 2020 | 227 | 0.140 |
Why?
| | Cell Nucleolus | 1 | 2018 | 17 | 0.140 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2017 | 333 | 0.140 |
Why?
| | Cyclooxygenase 2 | 1 | 2018 | 176 | 0.140 |
Why?
| | Immunity | 1 | 2018 | 140 | 0.140 |
Why?
| | Macaca mulatta | 3 | 2023 | 186 | 0.140 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2018 | 139 | 0.140 |
Why?
| | Translocation, Genetic | 1 | 2018 | 108 | 0.140 |
Why?
| | Consensus Sequence | 2 | 2016 | 73 | 0.140 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 258 | 0.140 |
Why?
| | Lymphocytes | 2 | 2017 | 395 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2021 | 264 | 0.140 |
Why?
| | Pyramidal Tracts | 2 | 2014 | 31 | 0.140 |
Why?
| | Retinal Pigment Epithelium | 1 | 2018 | 76 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 368 | 0.130 |
Why?
| | High-Throughput Screening Assays | 2 | 2016 | 155 | 0.130 |
Why?
| | Staining and Labeling | 1 | 2017 | 153 | 0.130 |
Why?
| | Splicing Factor U2AF | 1 | 2016 | 17 | 0.130 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2016 | 38 | 0.130 |
Why?
| | Histone Deacetylases | 1 | 2018 | 209 | 0.130 |
Why?
| | Genotype | 1 | 2021 | 1842 | 0.130 |
Why?
| | Genetic Testing | 1 | 2019 | 451 | 0.130 |
Why?
| | Histocompatibility, Maternal-Fetal | 1 | 2016 | 2 | 0.130 |
Why?
| | HLA-G Antigens | 1 | 2016 | 2 | 0.130 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 97 | 0.120 |
Why?
| | Kidney | 1 | 2004 | 1466 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 748 | 0.120 |
Why?
| | GTP-Binding Protein gamma Subunits | 1 | 2016 | 5 | 0.120 |
Why?
| | Support Vector Machine | 1 | 2016 | 37 | 0.120 |
Why?
| | Chromatin Assembly Factor-1 | 1 | 2015 | 12 | 0.120 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2016 | 121 | 0.120 |
Why?
| | Myocardium | 1 | 2021 | 921 | 0.120 |
Why?
| | Liver | 1 | 2004 | 1805 | 0.120 |
Why?
| | Methylation | 5 | 2020 | 227 | 0.120 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2015 | 18 | 0.120 |
Why?
| | Doxorubicin | 1 | 2017 | 348 | 0.120 |
Why?
| | PTEN Phosphohydrolase | 2 | 2016 | 163 | 0.120 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 255 | 0.120 |
Why?
| | Chondrocytes | 1 | 2018 | 226 | 0.120 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2015 | 23 | 0.120 |
Why?
| | Nervous System | 1 | 2015 | 67 | 0.120 |
Why?
| | rho GTP-Binding Proteins | 1 | 2016 | 60 | 0.120 |
Why?
| | Pseudogenes | 2 | 2014 | 18 | 0.120 |
Why?
| | Gene Expression | 4 | 2015 | 1488 | 0.120 |
Why?
| | Genes | 1 | 2015 | 227 | 0.120 |
Why?
| | Immunohistochemistry | 3 | 2015 | 1731 | 0.120 |
Why?
| | beta-Galactosidase | 1 | 2015 | 78 | 0.120 |
Why?
| | RNA, Protozoan | 1 | 2015 | 60 | 0.120 |
Why?
| | Myeloid Cells | 1 | 2016 | 151 | 0.110 |
Why?
| | Erythrocytes | 1 | 2020 | 701 | 0.110 |
Why?
| | STAT3 Transcription Factor | 1 | 2016 | 201 | 0.110 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 167 | 0.110 |
Why?
| | Gene Silencing | 2 | 2013 | 196 | 0.110 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 431 | 0.110 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 117 | 0.110 |
Why?
| | RNA, Catalytic | 1 | 2015 | 188 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 410 | 0.110 |
Why?
| | Lysine | 3 | 2020 | 290 | 0.110 |
Why?
| | Molecular Biology | 1 | 2015 | 60 | 0.110 |
Why?
| | Neocortex | 1 | 2014 | 38 | 0.110 |
Why?
| | Kinetics | 1 | 2018 | 1645 | 0.110 |
Why?
| | Pyramidal Cells | 1 | 2014 | 73 | 0.110 |
Why?
| | Protein Footprinting | 1 | 2014 | 11 | 0.110 |
Why?
| | Neurons | 2 | 2021 | 1601 | 0.110 |
Why?
| | Neurotransmitter Agents | 1 | 2014 | 81 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2018 | 633 | 0.110 |
Why?
| | Trophoblasts | 1 | 2016 | 200 | 0.100 |
Why?
| | Keratinocytes | 2 | 2012 | 251 | 0.100 |
Why?
| | Pregnancy | 4 | 2023 | 6829 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 37 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 1098 | 0.100 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2011 | 156 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 571 | 0.100 |
Why?
| | Information Theory | 1 | 2013 | 5 | 0.100 |
Why?
| | Nerve Tissue Proteins | 2 | 2014 | 600 | 0.100 |
Why?
| | Neuronal Plasticity | 1 | 2015 | 302 | 0.100 |
Why?
| | Fetus | 1 | 2017 | 799 | 0.100 |
Why?
| | Nervous System Diseases | 1 | 2015 | 273 | 0.100 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 67 | 0.100 |
Why?
| | Protein Array Analysis | 1 | 2012 | 56 | 0.100 |
Why?
| | Ubiquitination | 1 | 2013 | 105 | 0.100 |
Why?
| | Adipocytes, Brown | 1 | 2012 | 7 | 0.090 |
Why?
| | Mice, Transgenic | 5 | 2020 | 2172 | 0.090 |
Why?
| | Registries | 1 | 2020 | 2073 | 0.090 |
Why?
| | Models, Biological | 1 | 2019 | 1806 | 0.090 |
Why?
| | Adipocytes, White | 1 | 2012 | 19 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 186 | 0.090 |
Why?
| | Genes, Overlapping | 1 | 2011 | 2 | 0.090 |
Why?
| | Genome, Protozoan | 1 | 2011 | 3 | 0.090 |
Why?
| | Biological Evolution | 1 | 2015 | 479 | 0.090 |
Why?
| | Genes, Protozoan | 1 | 2011 | 13 | 0.090 |
Why?
| | Models, Statistical | 2 | 2024 | 663 | 0.090 |
Why?
| | Disease | 1 | 2012 | 102 | 0.090 |
Why?
| | Artifacts | 1 | 2011 | 130 | 0.080 |
Why?
| | Mitochondria | 2 | 2020 | 955 | 0.080 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 5 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2011 | 360 | 0.080 |
Why?
| | Colonic Neoplasms | 1 | 2013 | 245 | 0.080 |
Why?
| | Argonaute Proteins | 3 | 2016 | 27 | 0.080 |
Why?
| | Sexual Maturation | 1 | 2010 | 55 | 0.080 |
Why?
| | Octamer Transcription Factor-3 | 2 | 2021 | 18 | 0.080 |
Why?
| | Body Size | 1 | 2010 | 98 | 0.080 |
Why?
| | Insulin | 2 | 2018 | 2448 | 0.080 |
Why?
| | Thymus Gland | 2 | 2008 | 314 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2016 | 885 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 2 | 2010 | 553 | 0.070 |
Why?
| | Chromosome Mapping | 3 | 2004 | 502 | 0.070 |
Why?
| | Prostatic Neoplasms | 1 | 2016 | 1044 | 0.070 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2008 | 18 | 0.070 |
Why?
| | Zebrafish Proteins | 2 | 2010 | 287 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2010 | 232 | 0.070 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2009 | 70 | 0.070 |
Why?
| | Myosin Type V | 1 | 2008 | 9 | 0.070 |
Why?
| | Proteome | 1 | 2012 | 469 | 0.070 |
Why?
| | Wnt-5a Protein | 1 | 2008 | 25 | 0.070 |
Why?
| | Chromosome Disorders | 1 | 2008 | 43 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2009 | 325 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 2155 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 666 | 0.070 |
Why?
| | Keratins | 1 | 2008 | 171 | 0.070 |
Why?
| | Autoantigens | 2 | 2008 | 422 | 0.070 |
Why?
| | Cell Survival | 3 | 2016 | 1123 | 0.070 |
Why?
| | Genes, Reporter | 2 | 2020 | 274 | 0.070 |
Why?
| | Viruses | 1 | 2009 | 161 | 0.070 |
Why?
| | Zinc Fingers | 1 | 2007 | 49 | 0.070 |
Why?
| | Retinol-Binding Proteins | 1 | 2006 | 17 | 0.060 |
Why?
| | Peptides | 1 | 2012 | 976 | 0.060 |
Why?
| | Epithelium | 1 | 2008 | 316 | 0.060 |
Why?
| | Software | 1 | 2012 | 668 | 0.060 |
Why?
| | Bacteria | 2 | 2013 | 867 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 175 | 0.060 |
Why?
| | Protozoan Proteins | 1 | 2007 | 83 | 0.060 |
Why?
| | ras Proteins | 1 | 2007 | 148 | 0.060 |
Why?
| | Breast Neoplasms | 2 | 2016 | 2212 | 0.060 |
Why?
| | Wound Healing | 1 | 2009 | 345 | 0.060 |
Why?
| | Eye Proteins | 1 | 2006 | 93 | 0.060 |
Why?
| | Algorithms | 1 | 2014 | 1740 | 0.060 |
Why?
| | Dendritic Cells | 1 | 2009 | 491 | 0.060 |
Why?
| | Up-Regulation | 2 | 2020 | 851 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2006 | 330 | 0.060 |
Why?
| | Monocytes | 2 | 2020 | 573 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2021 | 626 | 0.060 |
Why?
| | Quantitative Trait Loci | 2 | 2020 | 361 | 0.060 |
Why?
| | Neoplastic Stem Cells | 1 | 2009 | 396 | 0.060 |
Why?
| | Transcortin | 1 | 2004 | 15 | 0.050 |
Why?
| | RNA Polymerase II | 2 | 2023 | 325 | 0.050 |
Why?
| | Levivirus | 1 | 2024 | 18 | 0.050 |
Why?
| | Biophysical Phenomena | 1 | 2024 | 64 | 0.050 |
Why?
| | Serpins | 1 | 2004 | 28 | 0.050 |
Why?
| | Metabolic Clearance Rate | 1 | 2004 | 116 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2008 | 402 | 0.050 |
Why?
| | Testis | 1 | 2004 | 157 | 0.050 |
Why?
| | Hypothalamus | 1 | 2004 | 153 | 0.050 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 145 | 0.050 |
Why?
| | Virus Internalization | 1 | 2023 | 64 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2016 | 136 | 0.050 |
Why?
| | Endoderm | 1 | 2023 | 20 | 0.050 |
Why?
| | SOXF Transcription Factors | 1 | 2023 | 16 | 0.050 |
Why?
| | Selection, Genetic | 1 | 2005 | 263 | 0.050 |
Why?
| | Poly A | 1 | 2003 | 52 | 0.050 |
Why?
| | Autoimmune Diseases | 1 | 2006 | 454 | 0.050 |
Why?
| | Ovary | 1 | 2004 | 223 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2022 | 18 | 0.050 |
Why?
| | Cytoskeletal Proteins | 2 | 2012 | 156 | 0.050 |
Why?
| | Neoplasm Invasiveness | 2 | 2016 | 501 | 0.050 |
Why?
| | Histone Demethylases | 2 | 2015 | 31 | 0.050 |
Why?
| | RNA, Small Untranslated | 1 | 2021 | 12 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 394 | 0.050 |
Why?
| | Macrophages | 2 | 2020 | 1543 | 0.050 |
Why?
| | Disease Models, Animal | 4 | 2017 | 4315 | 0.040 |
Why?
| | Smad1 Protein | 1 | 2020 | 17 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 210 | 0.040 |
Why?
| | Primates | 1 | 2022 | 139 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2020 | 8 | 0.040 |
Why?
| | Oligonucleotide Probes | 2 | 2015 | 50 | 0.040 |
Why?
| | Cochlear Nucleus | 1 | 2000 | 5 | 0.040 |
Why?
| | Gene Ontology | 1 | 2020 | 53 | 0.040 |
Why?
| | Bystander Effect | 1 | 2020 | 16 | 0.040 |
Why?
| | DNA Replication Timing | 1 | 2020 | 1 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 199 | 0.040 |
Why?
| | DNA Footprinting | 1 | 2020 | 33 | 0.040 |
Why?
| | Deoxyribonuclease I | 1 | 2020 | 39 | 0.040 |
Why?
| | Transposases | 1 | 2020 | 19 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 150 | 0.040 |
Why?
| | CpG Islands | 2 | 2015 | 155 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1068 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2000 | 52 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 684 | 0.040 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2020 | 99 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 183 | 0.040 |
Why?
| | Static Electricity | 1 | 2020 | 113 | 0.040 |
Why?
| | Cell Respiration | 1 | 2020 | 103 | 0.040 |
Why?
| | Genetic Variation | 1 | 2005 | 986 | 0.040 |
Why?
| | Karyotype | 1 | 2019 | 17 | 0.040 |
Why?
| | Karyotyping | 1 | 2019 | 103 | 0.040 |
Why?
| | Potassium Channels | 1 | 2000 | 149 | 0.040 |
Why?
| | Blastocyst | 1 | 2019 | 47 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 195 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 242 | 0.040 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 366 | 0.040 |
Why?
| | Cell Movement | 2 | 2016 | 969 | 0.040 |
Why?
| | Interphase | 1 | 2018 | 33 | 0.040 |
Why?
| | HL-60 Cells | 1 | 2018 | 33 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 359 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2850 | 0.040 |
Why?
| | Genes, Switch | 1 | 2018 | 6 | 0.040 |
Why?
| | Internet | 1 | 2003 | 669 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 12 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2014 | 1192 | 0.040 |
Why?
| | Regenerative Medicine | 1 | 2018 | 52 | 0.040 |
Why?
| | Cytarabine | 1 | 2018 | 63 | 0.040 |
Why?
| | GATA4 Transcription Factor | 1 | 2018 | 18 | 0.040 |
Why?
| | Biotinylation | 1 | 2017 | 32 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2018 | 113 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2018 | 67 | 0.030 |
Why?
| | A549 Cells | 1 | 2018 | 71 | 0.030 |
Why?
| | Inhibitor of Differentiation Protein 2 | 1 | 2017 | 4 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2018 | 68 | 0.030 |
Why?
| | Antigens, CD | 1 | 2020 | 536 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2017 | 57 | 0.030 |
Why?
| | Lymphocyte Subsets | 1 | 2017 | 88 | 0.030 |
Why?
| | Oncogene Protein pp60(v-src) | 1 | 2016 | 4 | 0.030 |
Why?
| | Pharmacogenetics | 1 | 2018 | 164 | 0.030 |
Why?
| | Mice, Nude | 2 | 2010 | 688 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2021 | 513 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2016 | 43 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2016 | 122 | 0.030 |
Why?
| | Macaca | 1 | 2016 | 65 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 523 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2020 | 522 | 0.030 |
Why?
| | Phosphorylation | 1 | 2021 | 1760 | 0.030 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 65 | 0.030 |
Why?
| | Immunogenetic Phenomena | 1 | 2016 | 7 | 0.030 |
Why?
| | Cell Fractionation | 1 | 2016 | 54 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1076 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2020 | 737 | 0.030 |
Why?
| | RNA Polymerase III | 1 | 2016 | 28 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1072 | 0.030 |
Why?
| | Mice, Inbred NOD | 2 | 2008 | 593 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2010 | 1262 | 0.030 |
Why?
| | Lipids | 1 | 2020 | 675 | 0.030 |
Why?
| | Heterochromatin | 1 | 2015 | 53 | 0.030 |
Why?
| | DNA Repair | 1 | 2017 | 229 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2015 | 136 | 0.030 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2014 | 7 | 0.030 |
Why?
| | Transcriptional Activation | 2 | 2010 | 376 | 0.030 |
Why?
| | Blood | 1 | 2015 | 113 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1587 | 0.030 |
Why?
| | Genes, Suppressor | 1 | 2014 | 4 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 116 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2014 | 70 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 941 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 241 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 395 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2015 | 220 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1110 | 0.030 |
Why?
| | Autoimmunity | 1 | 2020 | 903 | 0.030 |
Why?
| | Precipitin Tests | 2 | 2004 | 98 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2020 | 922 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2017 | 461 | 0.030 |
Why?
| | Membrane Transport Proteins | 1 | 2015 | 152 | 0.030 |
Why?
| | RNA Editing | 1 | 2014 | 24 | 0.030 |
Why?
| | Computer Simulation | 1 | 2018 | 996 | 0.030 |
Why?
| | Nucleosomes | 1 | 2015 | 153 | 0.030 |
Why?
| | Eosinophils | 1 | 2016 | 322 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 375 | 0.030 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2017 | 267 | 0.030 |
Why?
| | RNA Isoforms | 1 | 2013 | 1 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1230 | 0.030 |
Why?
| | Virus Replication | 1 | 2016 | 527 | 0.030 |
Why?
| | HapMap Project | 1 | 2013 | 5 | 0.030 |
Why?
| | Toll-Like Receptor 5 | 1 | 2013 | 14 | 0.030 |
Why?
| | Ataxins | 1 | 2013 | 4 | 0.020 |
Why?
| | Ataxin-1 | 1 | 2013 | 4 | 0.020 |
Why?
| | RNA Cap-Binding Proteins | 1 | 2013 | 3 | 0.020 |
Why?
| | ELAV Proteins | 1 | 2013 | 14 | 0.020 |
Why?
| | Flagellin | 1 | 2013 | 17 | 0.020 |
Why?
| | Neurogenesis | 1 | 2014 | 153 | 0.020 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 83 | 0.020 |
Why?
| | Cell Cycle | 1 | 2016 | 592 | 0.020 |
Why?
| | Lung | 2 | 2018 | 4106 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2013 | 383 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 148 | 0.020 |
Why?
| | Multigene Family | 1 | 2013 | 201 | 0.020 |
Why?
| | Cytokines | 1 | 2020 | 2080 | 0.020 |
Why?
| | Codon | 1 | 2012 | 91 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 320 | 0.020 |
Why?
| | Acetylation | 1 | 2013 | 244 | 0.020 |
Why?
| | Tretinoin | 1 | 2013 | 122 | 0.020 |
Why?
| | History, 21st Century | 1 | 2013 | 214 | 0.020 |
Why?
| | RNA Folding | 1 | 2012 | 35 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2339 | 0.020 |
Why?
| | Genetic Research | 1 | 2011 | 16 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 31 | 0.020 |
Why?
| | History, 20th Century | 1 | 2013 | 323 | 0.020 |
Why?
| | Adipose Tissue, White | 1 | 2012 | 43 | 0.020 |
Why?
| | 3T3 Cells | 1 | 2012 | 164 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2011 | 42 | 0.020 |
Why?
| | Adipose Tissue, Brown | 1 | 2012 | 55 | 0.020 |
Why?
| | Data Mining | 1 | 2012 | 115 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2012 | 192 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 174 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 262 | 0.020 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2012 | 60 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2013 | 316 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 208 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 368 | 0.020 |
Why?
| | Skin Diseases | 1 | 2012 | 145 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2013 | 191 | 0.020 |
Why?
| | PPAR gamma | 1 | 2012 | 180 | 0.020 |
Why?
| | Neutrophils | 1 | 2016 | 1274 | 0.020 |
Why?
| | Gene Dosage | 1 | 2011 | 141 | 0.020 |
Why?
| | Zygote | 1 | 2010 | 14 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2013 | 488 | 0.020 |
Why?
| | Lipopeptides | 1 | 2009 | 14 | 0.020 |
Why?
| | Bias | 1 | 2011 | 226 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2010 | 250 | 0.020 |
Why?
| | Career Choice | 1 | 2011 | 229 | 0.020 |
Why?
| | Poly I-C | 1 | 2009 | 63 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4092 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2009 | 81 | 0.020 |
Why?
| | Oncogene Proteins v-myb | 1 | 2009 | 1 | 0.020 |
Why?
| | HMGB3 Protein | 1 | 2009 | 1 | 0.020 |
Why?
| | Mice, SCID | 1 | 2010 | 368 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 309 | 0.020 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2009 | 55 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2009 | 189 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 363 | 0.020 |
Why?
| | Lacrimal Apparatus | 1 | 2008 | 9 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2009 | 120 | 0.020 |
Why?
| | Models, Animal | 1 | 2010 | 395 | 0.020 |
Why?
| | Salivary Glands | 1 | 2008 | 34 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2009 | 124 | 0.020 |
Why?
| | Polyribosomes | 1 | 2008 | 24 | 0.020 |
Why?
| | Secretory Vesicles | 1 | 2008 | 25 | 0.020 |
Why?
| | Vacuoles | 1 | 2008 | 40 | 0.020 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 16 | 0.020 |
Why?
| | Leukocytes | 1 | 2009 | 307 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2008 | 226 | 0.020 |
Why?
| | Eye | 1 | 2008 | 112 | 0.020 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2007 | 62 | 0.020 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2009 | 203 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2007 | 169 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 159 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 508 | 0.020 |
Why?
| | Actins | 1 | 2008 | 419 | 0.010 |
Why?
| | Survival Rate | 1 | 2010 | 1935 | 0.010 |
Why?
| | Uveitis | 1 | 2006 | 146 | 0.010 |
Why?
| | Glucose | 1 | 2010 | 1032 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 2004 | 188 | 0.010 |
Why?
| | Colforsin | 1 | 2004 | 48 | 0.010 |
Why?
| | Transcription Factor RelA | 1 | 2003 | 85 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2749 | 0.010 |
Why?
| | Quality Improvement | 1 | 2011 | 1213 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 3984 | 0.010 |
Why?
| | Shal Potassium Channels | 1 | 2000 | 5 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2000 | 54 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1352 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 2239 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 319 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1244 | 0.010 |
Why?
| | Middle Aged | 1 | 2010 | 33604 | 0.000 |
Why?
|
|
Rinn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|